559
The skin rash effect was most probably due, in first line, to olanzapine, but the cutaneous skin condition was triggered and aggravated by pravastatin, a 3-hydoxy-3-methylglutaryl-coenzyme A-(HMG-CoA)-reductase inhibitor, and lithium medication.
 skin rash effect: Effect; cutaneous skin condition: Effect; olanzapine,: Treatment; by pravastatin, a 3-hydoxy-3-methylglutaryl-coenzyme A-(HMG-CoA)-reductase inhibitor, and lithium: Treatment; olanzapine: Treatment.Drug; pravastatin: Treatment.Drug; lithium: Treatment.Drug; lithium: Combination.Drug; pravastatin: Combination.Drug; olanzapine: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 skin rash effect: Effect; cutaneous skin condition: Effect; olanzapine,: Treatment; by pravastatin, a 3-hydoxy-3-methylglutaryl-coenzyme A-(HMG-CoA)-reductase inhibitor, and lithium: Treatment; olanzapine: Treatment.Drug; pravastatin: Treatment.Drug; lithium: Treatment.Drug; lithium: Combination.Drug; pravastatin: Combination.Drug; olanzapine: Combination.Drug